T3 BioScience LLC started in 2013 as a university startup of University of Wisconsin-Milwaukee (UWM) and Duke Philanthropies. Since its days of inception, T3 has grown and capitalized the firm from external investors and employs own scientists that complement the UWM team of scientists. Jointly they execute the firm's mandate and the quest of fighting antibiotic resistance in humans. The relation with academia remains an important part of T3 BioScience's DNA and both, UWM through its research foundation UWMRF and Duke Philanthropies remain shareholders in T3.
Today, our laboratories continue to be located on campus at UWM.